Biochemical markers of type 1 diabetes: Clinical use

Scandinavian Journal of Clinical and Laboratory Investigation, Supplement

Volumn 61, Issue 235, 2001, Pages 38-44

  Pozzilli, P ^a   Manfrini, S ^a   Monetini, L ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; AUTOANTIGEN; BETA CASEIN; BIOCHEMICAL MARKER; CARBOXYPEPTIDASE H; GLUCOSE TRANSPORTER; GLUTAMATE DECARBOXYLASE; GLYCOLIPID; HEAT SHOCK PROTEIN 65; INSULIN; INSULIN RECEPTOR; PHOSPHOPROTEIN PHOSPHATASE 1; PROINSULIN; BIOLOGICAL MARKER; GLUTAMATE DECARBOXYLASE 65; ISOENZYME; PROTEIN TYROSINE PHOSPHATASE;

ANTIBODY PRODUCTION; ANTIGEN DETECTION; CLINICAL FEATURE; CONFERENCE PAPER; DIABETOGENESIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; ANIMAL; BLOOD; IMMUNOLOGY; REVIEW;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 1; GLUTAMATE DECARBOXYLASE; HUMANS; INSULIN; ISOENZYMES; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 0034740513     PISSN: 0085591X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. Insulin antibodies in insulin-dependent diabetics before insulin treatment
2. Relationen between insulin antibody and complement-fixing islet cell antibody at clinical diagnosis of IDDM
3. Concentration of insulin autoantibodies at onset of type 1 diabetes: Inverse log-linear correlation with age
4. Reactivity to human islets and fetal pig proislets by peripheral blood mononuclear cells from subjects with preclinical and clinical insulin-dependent diabetes
5. Insulin-specific human T cells. Epitope specificity, major histocompatibility complex restriction, and alloreactivity to a diabetes-associated haplotype
6. Autoimmune responses to the β cell autoantigen, insulin, and the INS VNTR-IDDM2 locus
7. Transgenic expression of mouse proinsulin II prevents diabetes in non obese diabetic mice
8. Proinsulin autoantibodies are more closely associated with type 1 (insulin-dependent) diabetes mellitus than insulin autoantibodies
9. Autoantibodies to the insulin receptor in juvenile onset insulin-dependent diabetes
10. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins
11. Revelation of specificity of 64K autoantibodies in IDDM serums by high-resolution 2-D gel electrophoresis
12. 64 000 Mr autoantibodies as predictors of insulin-dependent diabetes
13. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase
14. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene
15. Cloning, characterization, and autoimmune recognition of rat islet glutamic acid decarboxylase in insulin-dependent diabetes mellitus
16. Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin-dependent diabetes mellitus
17. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes
18. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes
19. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes
20. T cell proliferative responses to glutamic acid decarboxylase-65 in IDDM are negatively associated with HLA DR3/4
21. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2. from human insulinoma
22. 1A-2 auto-antibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings
23. Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD and ICA512bdc/IA-2 autoantibodies
24. Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD and ICA512bdc/IA-2 autoantibodies
25. IA-2 autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings
26. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes
27. Islet cell antibodies as predictive markers for IDDM in children with high background incidence of disease
28. Ten-year follow-up study of islet cell antibodies and childhood diabetes mellitus
29. Can islet cell antibodies predict IDDM in the general population?
30. Metabolic and immune parameters at clinical onset of insulin dependent diabetes: A population based study
31. Antibodies to tyrosine phophatase-like molecule in type 1 diabetes: A new predictive marker of the disease